WoundClot™ is a next generation hemostatic gauze, engineered to be effective in temporary management of mild, moderate, and severe bleeding. Our innovative Twin Pack features 2 pieces of WoundClot™ hemostatic gauze. This enables providers to effectively control post hemodialysis bleeding or post procedure bleeding in interventional medicine.
When WoundClot™ hemostatic gauze is applied to the site of bleeding, it rapidly converts from a dry fexible gauze to a thick, tenacious, expanding 3D gel matrix. This stable, strong, and pliant gel structure enables rapid and stable hemostasis to be achieved utilizing several mechanisms of action:
WoundClot™ hemostatic absorbs up to 3,000% of its weight in blood and remains actively absorbent for up to 24 hours.
WoundClot™’s pliant 3D gel matrix adheres to surrounding tissues in the wound.
Does not require the application of manual pressure to be effective.
A high safety profile and has no contraindications apart from hypersen-sitivity to the device materials.
Can be used anywhere on the body.
Available in a variety of sizes and conforms and anatomical shape effectively.
Zero toxicity – no harmful side effects or residues.
Simple to use and requires minimal training to be utilized effectively.
WoundClot™ is made from cellulose, a natural fiber product. WoundClot™ is NonOxidized, Non-Regenerated Cellulose Structure (NONRCS) product. Other hemostatics made from cellulose are manufactured utilizing a obsolete method that breaks down cellulose by oxidization, greatly decreasing the product’s ability to absorb blood, adhere to wound surfaces, and create an environment that is conducive to achieving hemostasis.
WoundClot™ is made from cellulose, a natural fiber product. Due to its unique patented manufacturing process, WoundClot™ does not require a “active Ingredient”. The material itself is engineered to be inherently hemostatic. Other hemostatics are made using a synthetic or natural substrate impregnated with an active ingredient like, kaolin, chitosan, collagen, silica, or thrombin.
Unlike any other hemostatic product available today, WoundClot™ has multiple mechanisms of action. When WoundClot™’s patented non-oxidized regenerated cellulosic structure contacts blood, it converts into a thick, tenacious, expanding gel, adhering to wound surfaces. WoundClot™ does not require the application of manual pressure to be effective. WoundClot™ is highly absorbent and will absorb up to 3,000% its weight in fluid. It also remains actively absorbent for up to 24 hours. WoundClot™ has a high safety profile and can be used anywhere on the body and requires little to no training to utilize effectively.
WoundClot™ is easily removed from wound by simply removing the clot. Rebleeding will not occur and any remaining gel can be easily irrigated out of the wound.
5 years shelf life.